APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Selected research

Market Analysis & Forecast

Global Radiopharmaceuticals Market Analysis and Forecast 2026-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

This report presents an overview of global market for Radiopharmaceuticals, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Radiopharmaceuticals, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceuticals, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiopharmaceuticals sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Radiopharmaceuticals sales, projected growth trends, production technology, application and end-user industry.

Radiopharmaceuticals Segment by Company

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Radiopharmaceuticals Segment by Type

Diagnostic Radioisotopes

Therapeutic Radioisotopes

Radiopharmaceuticals Segment by Application

Oncology

Cardiology

Other

Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Radiopharmaceuticals in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceuticals sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diagnostic Radioisotopes Major Manufacturers Table 3. Therapeutic Radioisotopes Major Manufacturers Table 4. Global Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Oncology Major Manufacturers Table 6. Cardiology Major Manufacturers Table 7. Other Major Manufacturers Table 8. Radiopharmaceuticals Industry Trends Table 9. Radiopharmaceuticals Industry Drivers Table 10. Radiopharmaceuticals Industry Opportunities and Challenges Table 11. Radiopharmaceuticals Industry Restraints Table 12. Global Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 16. Global Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 17. Global Radiopharmaceuticals Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Dose) Table 18. Global Radiopharmaceuticals Sales by Region (2021-2026) & (K Dose) Table 19. Global Radiopharmaceuticals Sales by Region (2027-2032) & (K Dose) Table 20. Global Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 21. Global Radiopharmaceuticals Sales Market Share by Region (2027-2032) Table 22. Global Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Radiopharmaceuticals Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026) Table 26. Global Radiopharmaceuticals Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 27. Global Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Radiopharmaceuticals Manufacturers, Product Type & Application Table 30. Global Radiopharmaceuticals Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 37. Global Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 38. Global Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (K Dose) Table 39. Global Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 40. Global Radiopharmaceuticals Sales by Type (2027-2032) & (K Dose) Table 41. Global Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 42. Global Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 43. Global Radiopharmaceuticals Price by Type (2021-2026) & (US$/Dose) Table 44. Global Radiopharmaceuticals Price by Type (2027-2032) & (US$/Dose) Table 45. Global Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 49. Global Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 50. Global Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (K Dose) Table 51. Global Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 52. Global Radiopharmaceuticals Sales by Application (2027-2032) & (K Dose) Table 53. Global Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 54. Global Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 55. Global Radiopharmaceuticals Price by Application (2021-2026) & (US$/Dose) Table 56. Global Radiopharmaceuticals Price by Application (2027-2032) & (US$/Dose) Table 57. Bracco Imaging Company Information Table 58. Bracco Imaging Business Overview Table 59. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 60. Bracco Imaging Radiopharmaceuticals Product Portfolio Table 61. Bracco Imaging Recent Development Table 62. Bayer Company Information Table 63. Bayer Business Overview Table 64. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 65. Bayer Radiopharmaceuticals Product Portfolio Table 66. Bayer Recent Development Table 67. Mallinckrodt Company Information Table 68. Mallinckrodt Business Overview Table 69. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 70. Mallinckrodt Radiopharmaceuticals Product Portfolio Table 71. Mallinckrodt Recent Development Table 72. Nordion Company Information Table 73. Nordion Business Overview Table 74. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 75. Nordion Radiopharmaceuticals Product Portfolio Table 76. Nordion Recent Development Table 77. Triad Isotopes Company Information Table 78. Triad Isotopes Business Overview Table 79. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 80. Triad Isotopes Radiopharmaceuticals Product Portfolio Table 81. Triad Isotopes Recent Development Table 82. Lantheus Company Information Table 83. Lantheus Business Overview Table 84. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 85. Lantheus Radiopharmaceuticals Product Portfolio Table 86. Lantheus Recent Development Table 87. IBA Group Company Information Table 88. IBA Group Business Overview Table 89. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 90. IBA Group Radiopharmaceuticals Product Portfolio Table 91. IBA Group Recent Development Table 92. GE Healthcare Company Information Table 93. GE Healthcare Business Overview Table 94. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 95. GE Healthcare Radiopharmaceuticals Product Portfolio Table 96. GE Healthcare Recent Development Table 97. China Isotope & Radiation Company Information Table 98. China Isotope & Radiation Business Overview Table 99. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 100. China Isotope & Radiation Radiopharmaceuticals Product Portfolio Table 101. China Isotope & Radiation Recent Development Table 102. Jubilant Pharma Company Information Table 103. Jubilant Pharma Business Overview Table 104. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 105. Jubilant Pharma Radiopharmaceuticals Product Portfolio Table 106. Jubilant Pharma Recent Development Table 107. Eli Lilly Company Information Table 108. Eli Lilly Business Overview Table 109. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 110. Eli Lilly Radiopharmaceuticals Product Portfolio Table 111. Eli Lilly Recent Development Table 112. Advanced Accelerator Applications Company Information Table 113. Advanced Accelerator Applications Business Overview Table 114. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 115. Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio Table 116. Advanced Accelerator Applications Recent Development Table 117. SIEMENS Company Information Table 118. SIEMENS Business Overview Table 119. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 120. SIEMENS Radiopharmaceuticals Product Portfolio Table 121. SIEMENS Recent Development Table 122. Dongcheng Company Information Table 123. Dongcheng Business Overview Table 124. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 125. Dongcheng Radiopharmaceuticals Product Portfolio Table 126. Dongcheng Recent Development Table 127. Navidea Company Information Table 128. Navidea Business Overview Table 129. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 130. Navidea Radiopharmaceuticals Product Portfolio Table 131. Navidea Recent Development Table 132. North America Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 135. North America Radiopharmaceuticals Sales by Type (2027-2032) & (K Dose) Table 136. North America Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Dose) Table 137. North America Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Dose) Table 138. North America Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 141. North America Radiopharmaceuticals Sales by Application (2027-2032) & (K Dose) Table 142. North America Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Dose) Table 143. North America Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Dose) Table 144. North America Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 148. North America Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 149. North America Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 150. North America Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Dose) Table 151. North America Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Dose) Table 152. United States Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 153. Canada Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 154. Mexico Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 155. Europe Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 158. Europe Radiopharmaceuticals Sales by Type (2027-2032) & (K Dose) Table 159. Europe Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Dose) Table 160. Europe Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Dose) Table 161. Europe Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 164. Europe Radiopharmaceuticals Sales by Application (2027-2032) & (K Dose) Table 165. Europe Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Dose) Table 166. Europe Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Dose) Table 167. Europe Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 171. Europe Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 172. Europe Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 173. Europe Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Dose) Table 174. Europe Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Dose) Table 175. Germany Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 176. France Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 177. U.K. Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 178. Italy Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 179. Russia Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 180. Spain Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 182. Switzerland Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 183. Sweden Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 184. Poland Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 185. China Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 186. China Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 187. China Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 188. China Radiopharmaceuticals Sales by Type (2027-2032) & (K Dose) Table 189. China Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Dose) Table 190. China Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Dose) Table 191. China Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 192. China Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 193. China Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 194. China Radiopharmaceuticals Sales by Application (2027-2032) & (K Dose) Table 195. China Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Dose) Table 196. China Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Dose) Table 197. Asia Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 198. Asia Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 199. Asia Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 200. Asia Radiopharmaceuticals Sales by Type (2027-2032) & (K Dose) Table 201. Asia Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Dose) Table 202. Asia Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Dose) Table 203. Asia Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 206. Asia Radiopharmaceuticals Sales by Application (2027-2032) & (K Dose) Table 207. Asia Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Dose) Table 208. Asia Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Dose) Table 209. Asia Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 213. Asia Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 214. Asia Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 215. Asia Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Dose) Table 216. Asia Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Dose) Table 217. Japan Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 218. South Korea Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 219. India Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 220. Australia Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 221. Taiwan Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Radiopharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 224. SAMEA Radiopharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 225. SAMEA Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 226. SAMEA Radiopharmaceuticals Sales by Type (2027-2032) & (K Dose) Table 227. SAMEA Radiopharmaceuticals Sales Price by Type (2021-2026) & (US$/Dose) Table 228. SAMEA Radiopharmaceuticals Sales Price by Type (2027-2032) & (US$/Dose) Table 229. SAMEA Radiopharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Radiopharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 232. SAMEA Radiopharmaceuticals Sales by Application (2027-2032) & (K Dose) Table 233. SAMEA Radiopharmaceuticals Sales Price by Application (2021-2026) & (US$/Dose) Table 234. SAMEA Radiopharmaceuticals Sales Price by Application (2027-2032) & (US$/Dose) Table 235. SAMEA Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Radiopharmaceuticals Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Radiopharmaceuticals Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032) & (K Dose) Table 239. SAMEA Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 240. SAMEA Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 241. SAMEA Radiopharmaceuticals Sales Price by Country (2021-2026) & (US$/Dose) Table 242. SAMEA Radiopharmaceuticals Sales Price by Country (2027-2032) & (US$/Dose) Table 243. Brazil Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 244. Argentina Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 245. Chile Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 246. Colombia Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 247. Peru Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 249. Israel Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 250. UAE Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 251. Turkey Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 252. Iran Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 253. Egypt Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Radiopharmaceuticals Distributors List Table 257. Radiopharmaceuticals Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Radiopharmaceuticals Image Figure 2. Global Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diagnostic Radioisotopes Image Figure 5. Therapeutic Radioisotopes Image Figure 6. Global Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Radiopharmaceuticals Market Size Share 2021 VS 2025 VS 2032 Figure 8. Oncology Image Figure 9. Cardiology Image Figure 10. Other Image Figure 11. Global Radiopharmaceuticals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 13. Global Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Radiopharmaceuticals Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Radiopharmaceuticals Revenue Market Share by Region (2021-2032) Figure 16. Global Radiopharmaceuticals Sales (2021-2032) & (K Dose) Figure 17. Global Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Figure 18. Global Radiopharmaceuticals Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Radiopharmaceuticals Sales YoY (2021-2032) & (K Dose) Figure 20. Europe Radiopharmaceuticals Sales YoY (2021-2032) & (K Dose) Figure 21. China Radiopharmaceuticals Sales YoY (2021-2032) & (K Dose) Figure 22. Asia (Excluding China) Radiopharmaceuticals Sales YoY (2021-2032) & (K Dose) Figure 23. South America, Middle East and Africa Radiopharmaceuticals Sales YoY (2021-2032) & (K Dose) Figure 24. Global Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Radiopharmaceuticals Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 30. Global Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 31. Global Radiopharmaceuticals Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 33. Global Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Radiopharmaceuticals Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 36. Global Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 37. Global Radiopharmaceuticals Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 39. North America Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 40. North America Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 41. North America Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 42. North America Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 43. North America Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 44. North America Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 45. Europe Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 46. Europe Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 47. Europe Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 48. Europe Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 49. Europe Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 50. Europe Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 51. China Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 52. China Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 53. China Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 54. China Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 55. Asia Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 56. Asia Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 57. Asia Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 58. Asia Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 59. Asia Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 60. Asia Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 61. SAMEA Radiopharmaceuticals Revenue Share by Type (2021-2032) Figure 62. SAMEA Radiopharmaceuticals Sales Share by Type (2021-2032) Figure 63. SAMEA Radiopharmaceuticals Revenue Share by Application (2021-2032) Figure 64. SAMEA Radiopharmaceuticals Sales Share by Application (2021-2032) Figure 65. SAMEA Radiopharmaceuticals Revenue Share by Country (2021-2032) Figure 66. SAMEA Radiopharmaceuticals Sales Share by Country (2021-2032) Figure 67. Radiopharmaceuticals Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Radiopharmaceuticals Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radiopharmaceuticals Market by Type
  3. 1.2.1 Global Radiopharmaceuticals Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostic Radioisotopes
  5. 1.2.3 Therapeutic Radioisotopes
  6. 1.3 Radiopharmaceuticals Market by Application
  7. 1.3.1 Global Radiopharmaceuticals Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Oncology
  9. 1.3.3 Cardiology
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Radiopharmaceuticals Market Dynamics
  1. 2.1 Radiopharmaceuticals Industry Trends
  2. 2.2 Radiopharmaceuticals Industry Drivers
  3. 2.3 Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Radiopharmaceuticals Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Radiopharmaceuticals Revenue by Region
  3. 3.2.1 Global Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radiopharmaceuticals Revenue by Region (2021-2026)
  5. 3.2.3 Global Radiopharmaceuticals Revenue by Region (2027-2032)
  6. 3.2.4 Global Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Radiopharmaceuticals Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Radiopharmaceuticals Sales by Region
  9. 3.4.1 Global Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Radiopharmaceuticals Sales by Region (2021-2026)
  11. 3.4.3 Global Radiopharmaceuticals Sales by Region (2027-2032)
  12. 3.4.4 Global Radiopharmaceuticals Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Radiopharmaceuticals Revenue by Manufacturers
  2. 4.1.1 Global Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Radiopharmaceuticals Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radiopharmaceuticals Sales by Manufacturers
  6. 4.2.1 Global Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Radiopharmaceuticals Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Radiopharmaceuticals Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Radiopharmaceuticals Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Radiopharmaceuticals Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Radiopharmaceuticals Manufacturers, Product Type & Application
  13. 4.7 Global Radiopharmaceuticals Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Radiopharmaceuticals Market CR5 and HHI
  16. 4.8.2 2025 Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
5 Radiopharmaceuticals Market by Type
  1. 5.1 Global Radiopharmaceuticals Revenue by Type
  2. 5.1.1 Global Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Radiopharmaceuticals Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Radiopharmaceuticals Sales by Type
  6. 5.2.1 Global Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceuticals Sales by Type (2021-2032) & (K Dose)
  8. 5.2.3 Global Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  9. 5.3 Global Radiopharmaceuticals Price by Type
6 Radiopharmaceuticals Market by Application
  1. 6.1 Global Radiopharmaceuticals Revenue by Application
  2. 6.1.1 Global Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Radiopharmaceuticals Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Radiopharmaceuticals Sales by Application
  6. 6.2.1 Global Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Radiopharmaceuticals Sales by Application (2021-2032) & (K Dose)
  8. 6.2.3 Global Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  9. 6.3 Global Radiopharmaceuticals Price by Application
7 Company Profiles
  1. 7.1 Bracco Imaging
  2. 7.1.1 Bracco Imaging Company Information
  3. 7.1.2 Bracco Imaging Business Overview
  4. 7.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bracco Imaging Radiopharmaceuticals Product Portfolio
  6. 7.1.5 Bracco Imaging Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Radiopharmaceuticals Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Mallinckrodt
  14. 7.3.1 Mallinckrodt Company Information
  15. 7.3.2 Mallinckrodt Business Overview
  16. 7.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mallinckrodt Radiopharmaceuticals Product Portfolio
  18. 7.3.5 Mallinckrodt Recent Developments
  19. 7.4 Nordion
  20. 7.4.1 Nordion Company Information
  21. 7.4.2 Nordion Business Overview
  22. 7.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Nordion Radiopharmaceuticals Product Portfolio
  24. 7.4.5 Nordion Recent Developments
  25. 7.5 Triad Isotopes
  26. 7.5.1 Triad Isotopes Company Information
  27. 7.5.2 Triad Isotopes Business Overview
  28. 7.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Triad Isotopes Radiopharmaceuticals Product Portfolio
  30. 7.5.5 Triad Isotopes Recent Developments
  31. 7.6 Lantheus
  32. 7.6.1 Lantheus Company Information
  33. 7.6.2 Lantheus Business Overview
  34. 7.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lantheus Radiopharmaceuticals Product Portfolio
  36. 7.6.5 Lantheus Recent Developments
  37. 7.7 IBA Group
  38. 7.7.1 IBA Group Company Information
  39. 7.7.2 IBA Group Business Overview
  40. 7.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 IBA Group Radiopharmaceuticals Product Portfolio
  42. 7.7.5 IBA Group Recent Developments
  43. 7.8 GE Healthcare
  44. 7.8.1 GE Healthcare Company Information
  45. 7.8.2 GE Healthcare Business Overview
  46. 7.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GE Healthcare Radiopharmaceuticals Product Portfolio
  48. 7.8.5 GE Healthcare Recent Developments
  49. 7.9 China Isotope & Radiation
  50. 7.9.1 China Isotope & Radiation Company Information
  51. 7.9.2 China Isotope & Radiation Business Overview
  52. 7.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 China Isotope & Radiation Radiopharmaceuticals Product Portfolio
  54. 7.9.5 China Isotope & Radiation Recent Developments
  55. 7.10 Jubilant Pharma
  56. 7.10.1 Jubilant Pharma Company Information
  57. 7.10.2 Jubilant Pharma Business Overview
  58. 7.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Jubilant Pharma Radiopharmaceuticals Product Portfolio
  60. 7.10.5 Jubilant Pharma Recent Developments
  61. 7.11 Eli Lilly
  62. 7.11.1 Eli Lilly Company Information
  63. 7.11.2 Eli Lilly Business Overview
  64. 7.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Eli Lilly Radiopharmaceuticals Product Portfolio
  66. 7.11.5 Eli Lilly Recent Developments
  67. 7.12 Advanced Accelerator Applications
  68. 7.12.1 Advanced Accelerator Applications Company Information
  69. 7.12.2 Advanced Accelerator Applications Business Overview
  70. 7.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio
  72. 7.12.5 Advanced Accelerator Applications Recent Developments
  73. 7.13 SIEMENS
  74. 7.13.1 SIEMENS Company Information
  75. 7.13.2 SIEMENS Business Overview
  76. 7.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 SIEMENS Radiopharmaceuticals Product Portfolio
  78. 7.13.5 SIEMENS Recent Developments
  79. 7.14 Dongcheng
  80. 7.14.1 Dongcheng Company Information
  81. 7.14.2 Dongcheng Business Overview
  82. 7.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Dongcheng Radiopharmaceuticals Product Portfolio
  84. 7.14.5 Dongcheng Recent Developments
  85. 7.15 Navidea
  86. 7.15.1 Navidea Company Information
  87. 7.15.2 Navidea Business Overview
  88. 7.15.3 Navidea Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Navidea Radiopharmaceuticals Product Portfolio
  90. 7.15.5 Navidea Recent Developments
8 North America
  1. 8.1 North America Radiopharmaceuticals Market Size by Type
  2. 8.1.1 North America Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 8.1.2 North America Radiopharmaceuticals Sales by Type (2021-2032)
  4. 8.1.3 North America Radiopharmaceuticals Price by Type (2021-2032)
  5. 8.2 North America Radiopharmaceuticals Market Size by Application
  6. 8.2.1 North America Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 8.2.2 North America Radiopharmaceuticals Sales by Application (2021-2032)
  8. 8.2.3 North America Radiopharmaceuticals Price by Application (2021-2032)
  9. 8.3 North America Radiopharmaceuticals Market Size by Country
  10. 8.3.1 North America Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Radiopharmaceuticals Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Radiopharmaceuticals Market Size by Type
  2. 9.1.1 Europe Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 9.1.2 Europe Radiopharmaceuticals Sales by Type (2021-2032)
  4. 9.1.3 Europe Radiopharmaceuticals Price by Type (2021-2032)
  5. 9.2 Europe Radiopharmaceuticals Market Size by Application
  6. 9.2.1 Europe Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 9.2.2 Europe Radiopharmaceuticals Sales by Application (2021-2032)
  8. 9.2.3 Europe Radiopharmaceuticals Price by Application (2021-2032)
  9. 9.3 Europe Radiopharmaceuticals Market Size by Country
  10. 9.3.1 Europe Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Radiopharmaceuticals Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Radiopharmaceuticals Market Size by Type
  2. 10.1.1 China Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 10.1.2 China Radiopharmaceuticals Sales by Type (2021-2032)
  4. 10.1.3 China Radiopharmaceuticals Price by Type (2021-2032)
  5. 10.2 China Radiopharmaceuticals Market Size by Application
  6. 10.2.1 China Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 10.2.2 China Radiopharmaceuticals Sales by Application (2021-2032)
  8. 10.2.3 China Radiopharmaceuticals Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radiopharmaceuticals Market Size by Type
  2. 11.1.1 Asia Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 11.1.2 Asia Radiopharmaceuticals Sales by Type (2021-2032)
  4. 11.1.3 Asia Radiopharmaceuticals Price by Type (2021-2032)
  5. 11.2 Asia Radiopharmaceuticals Market Size by Application
  6. 11.2.1 Asia Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 11.2.2 Asia Radiopharmaceuticals Sales by Application (2021-2032)
  8. 11.2.3 Asia Radiopharmaceuticals Price by Application (2021-2032)
  9. 11.3 Asia Radiopharmaceuticals Market Size by Country
  10. 11.3.1 Asia Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Radiopharmaceuticals Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radiopharmaceuticals Market Size by Type
  2. 12.1.1 SAMEA Radiopharmaceuticals Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Radiopharmaceuticals Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Radiopharmaceuticals Price by Type (2021-2032)
  5. 12.2 SAMEA Radiopharmaceuticals Market Size by Application
  6. 12.2.1 SAMEA Radiopharmaceuticals Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Radiopharmaceuticals Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Radiopharmaceuticals Price by Application (2021-2032)
  9. 12.3 SAMEA Radiopharmaceuticals Market Size by Country
  10. 12.3.1 SAMEA Radiopharmaceuticals Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Radiopharmaceuticals Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Radiopharmaceuticals Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Radiopharmaceuticals Value Chain Analysis
  2. 13.1.1 Radiopharmaceuticals Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Radiopharmaceuticals Production Mode & Process
  6. 13.2 Radiopharmaceuticals Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Radiopharmaceuticals Distributors
  9. 13.2.3 Radiopharmaceuticals Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst